VAERS reports by lot

Janssen (J&J) COVID-19 lot 59676-0580-15: VAERS reports

33 VAERS reports list lot 59676-0580-15 as a Janssen (J&J) COVID-19 vaccine, received between 2021-03-10 and 2022-09-09. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
33
Reports
9%
Marked serious
0
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)6030%
Neurological4221%
Musculoskeletal2714%
Gastrointestinal189%
Dermatological (non-injection-site)126%
Cardiac / Cardiovascular116%
Thrombotic / Hematological74%
Respiratory63%
Allergic / Anaphylactic53%
Injection-site / Local reaction53%
Psychiatric / Neuropsychiatric32%
Autoimmune / Immune-mediated11%
Reproductive / Menstrual11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Oregon3
Virginia3
North Carolina3
Maryland2
California2
Maine2
Idaho2
Illinois2
Kentucky1
Utah1
Connecticut1
New York1

Reports by month received

2021-034
2021-0410
2021-054
2021-063
2021-072
2021-081
2021-094
2021-112
2022-011
2022-071
2022-091

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.